Clinical Trial Update: Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating autologous activated platelet-rich plasma therapy for managing cytokine storms in severe COVID-19 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Covid19
• Respiratory Distress Syndrome

Drugs mentioned

• Autologous activated platelet-rich plasma therapy

Snippet

Sponsor: Hayandra Peduli Foundation | Conditions: Covid19, Sars-CoV-2 Infection | Phase 1, Phase 2 | Status: UNKNOWN